1. 100 years of inherited metabolic disorders in Austria—A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021. Issue 2 (17th October 2021) Authors: Ramoser, Gabriele; Caferri, Federica; Radlinger, Bernhard; Brunner‐Krainz, Michaela; Herbst, Sybille; Huemer, Martina; Hufgard‐Leitner, Miriam; Kircher, Susanne G.; Konstantopoulou, Vassiliki; Löscher, Wolfgang; Möslinger, Dorothea; Plecko, Barbara; Spenger, Johannes; Stulnig, Thomas; Sunder‐Plas... Journal: Journal of inherited metabolic disease Issue: Volume 45:Issue 2(2022) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia. (6th May 2021) Authors: Johne, Marie; Käufer, Christopher; Römermann, Kerstin; Gailus, Björn; Gericke, Birthe; Löscher, Wolfgang Journal: Epilepsia Issue: Volume 62:issue 6(2021) Page Start: 1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force. (15th September 2018) Authors: Barker‐Haliski, Melissa; Harte‐Hargrove, Lauren C.; Ravizza, Teresa; Smolders, Ilse; Xiao, Bo; Brandt, Claudia; Löscher, Wolfgang Journal: Epilepsia open Issue: Volume 3(2018)Supplement 1 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A face‐to‐face comparison of the intra‐amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies. (11th December 2019) Authors: Welzel, Lisa; Schidlitzki, Alina; Twele, Friederike; Anjum, Muneeb; Löscher, Wolfgang Journal: Epilepsia Issue: Volume 61:issue 1(2020) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A novel prodrug‐based strategy to increase effects of bumetanide in epilepsy. Issue 4 (2nd April 2014) Authors: Töllner, Kathrin; Brandt, Claudia; Töpfer, Manuel; Brunhofer, Gerda; Erker, Thomas; Gabriel, Mario; Feit, Peter W.; Lindfors, Jenna; Kaila, Kai; Löscher, Wolfgang Journal: Annals of neurology Issue: Volume 75:Issue 4(2014:Apr.) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Advances in the development of biomarkers for epilepsy. Issue 8 (July 2016) Authors: Pitkänen, Asla; Löscher, Wolfgang; Vezzani, Annamaria; Becker, Albert J; Simonato, Michele; Lukasiuk, Katarzyna; Gröhn, Olli; Bankstahl, Jens P; Friedman, Alon; Aronica, Eleonora; Gorter, Jan A; Ravizza, Teresa; Sisodiya, Sanjay M; Kokaia, Merab; Beck, Heinz Journal: Lancet neurology Issue: Volume 15:Issue 8(2016:Jul.) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anticonvulsant Effects by Bilateral and Unilateral Transplantation of GABA-Producing Cells into the Subthalamic Nucleus in an Acute Seizure Model. Issue 1 (February 2014) Authors: Handreck, Annelie; Backofen-Wehrhahn, Bianca; Bröer, Sonja; Löscher, Wolfgang; Gernert, Manuela Journal: Cell transplantation Issue: Volume 23:Issue 1(2014) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop. Issue 2 (6th May 2021) Authors: Galanopoulou, Aristea S.; Löscher, Wolfgang; Lubbers, Laura; O'Brien, Terence J.; Staley, Kevin; Vezzani, Annamaria; D'Ambrosio, Raimondo; White, H. Steve; Sontheimer, Harald; Wolf, John A.; Twyman, Roy; Whittemore, Vicky; Wilcox, Karen S.; Klein, Brian Journal: Epilepsia open Issue: Volume 6:Issue 2(2021) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy. (December 2018) Authors: Brandt, Claudia; Seja, Patricia; Töllner, Kathrin; Römermann, Kerstin; Hampel, Philip; Kalesse, Markus; Kipper, Andi; Feit, Peter W.; Lykke, Kasper; Toft-Bertelsen, Trine Lisberg; Paavilainen, Pauliina; Spoljaric, Inkeri; Puskarjov, Martin; MacAulay, Nanna; Kaila, Kai; Löscher, Wolfgang Journal: Neuropharmacology Issue: Volume 143(2018) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel. Issue 7 (26th May 2022) Authors: Kaila, Kai; Löscher, Wolfgang Journal: Epilepsia Issue: Volume 63:Issue 7(2022) Page Start: 1868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗